{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:00:11Z","timestamp":1785218411309,"version":"3.55.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ60019"],"award-info":[{"award-number":["2023JJ60019"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ6326"],"award-info":[{"award-number":["2024JJ6326"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"<jats:p>\n                    TRPV6 is a member of the transient receptor potential cation channel family with selective permeability to Ca\n                    <jats:sup>2+<\/jats:sup>\n                    . Research indicates that TRPV6 is involved in the promotion of tumor cell proliferation and metastasis in various cancers, rendering it a prospective therapeutic target in cancer treatment. Thus, TRPV6 inhibitors are a very promising avenue for research into novel anti-tumor drugs. Nevertheless, the development of TRPV6 inhibitors remains in the preliminary stage, and the existing TRPV6 inhibitors demonstrate inadequate selectivity and off-target effects. Currently, the development of new drugs is being accelerated greatly by virtual screening technology, as is the reduction of research and development costs. In the present study, a novel TRPV6 inhibitor, designated AZ191, was identified through a structure-based virtual screening process utilizing the MCE and TOPSCIENCE databases. Electrophysiological experiments demonstrated that the compound AZ191 exhibited a high degree of affinity for hTRPV6, with an IC\n                    <jats:sub>50<\/jats:sub>\n                    of 3.83 \u00b1 0.32\u00a0\u03bcM.\n                    <jats:italic>In vitro<\/jats:italic>\n                    experiments have demonstrated the efficacy of compound AZ191 in combating tumors by virtue of its inhibitory effect on TRPV6. Notably, our study further demonstrates the good potential of TRPV6 inhibitors as novel anti-cancer drugs and provides a good lead compound for TRPV6 inhibitor research.\n                  <\/jats:p>","DOI":"10.3389\/fchem.2026.1876502","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:35:14Z","timestamp":1785216914000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of the small molecular inhibitors against TRPV6 as potential anti-cancer agents by structural based virtual screening"],"prefix":"10.3389","volume":"14","author":[{"given":"Lixuan","family":"Wang","sequence":"first","affiliation":[{"name":"Hunan Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutical Sciences, Hunan Normal University","place":["Changsha, China"]},{"name":"Engineering Research Center of Reproduction and Translational Medicine of Hunan Province, Hunan Normal University Health Science Center","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Deng","sequence":"additional","affiliation":[{"name":"Hunan Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutical Sciences, Hunan Normal University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyang","family":"Hu","sequence":"additional","affiliation":[{"name":"Hunan Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutical Sciences, Hunan Normal University","place":["Changsha, China"]},{"name":"Engineering Research Center of Reproduction and Translational Medicine of Hunan Province, Hunan Normal University Health Science Center","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuguang","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital","place":["Hengyang, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Hunan Normal University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqiang","family":"Rong","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Hunan Normal University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Hu","sequence":"additional","affiliation":[{"name":"Hunan Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutical Sciences, Hunan Normal University","place":["Changsha, China"]},{"name":"Engineering Research Center of Reproduction and Translational Medicine of Hunan Province, Hunan Normal University Health Science Center","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Feng","sequence":"additional","affiliation":[{"name":"Hunan Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutical Sciences, Hunan Normal University","place":["Changsha, China"]},{"name":"Engineering Research Center of Reproduction and Translational Medicine of Hunan Province, Hunan Normal University Health Science Center","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zou","sequence":"additional","affiliation":[{"name":"Hunan Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutical Sciences, Hunan Normal University","place":["Changsha, China"]},{"name":"Engineering Research Center of Reproduction and Translational Medicine of Hunan Province, Hunan Normal University Health Science Center","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital","place":["Hengyang, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/s0140-6736(20)30164-1","article-title":"Small molecules, big impact: 20 years of targeted therapy in oncology","volume":"395","author":"Bedard","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"eabe1508","DOI":"10.1126\/sciadv.abe1508","article-title":"Inactivation-mimicking block of the epithelial calcium channel TRPV6","volume":"6","author":"Bhardwaj","year":"2020","journal-title":"Sci. Adv."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1021\/jm100112j","article-title":"A medicinal chemist\u2019s guide to molecular interactions","volume":"53","author":"Bissantz","year":"2010","journal-title":"J. Med. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.cellsig.2006.08.012","article-title":"TRP proteins and cancer","volume":"19","author":"B\u00f6dding","year":"2007","journal-title":"Cell Signal"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e58866","DOI":"10.1371\/journal.pone.0058866","article-title":"In vivo detection of human TRPV6-rich tumors with anti-cancer peptides derived from soricidin","volume":"8","author":"Bowen","year":"2013","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-025-02376-8","article-title":"Targeting TRPV6\/CXCR4 complexes prevents castration-resistant prostate cancer metastasis to the bone","volume":"10","author":"Cordier","year":"2025","journal-title":"Signal Transduct. Tar"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1039\/d0md00145g","article-title":"Natural product inspired optimization of a selective TRPV6 calcium channel inhibitor","volume":"11","author":"Cunha","year":"2020","journal-title":"Rsc Med. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"8869","DOI":"10.1073\/pnas.1820323116","article-title":"Structural insight into TRPV5 channel function and modulation","volume":"116","author":"Dang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0143-4160(03)00065-4","article-title":"The epithelial calcium channels, TRPV5 and TRPV6: from identification towards regulation","volume":"33","author":"den Dekker","year":"2003","journal-title":"Cell Calcium"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s10637-017-0438-z","article-title":"First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors","volume":"35","author":"Fu","year":"2017","journal-title":"Invest New Drugs"},{"key":"B12","doi-asserted-by":"publisher","first-page":"a003962","DOI":"10.1101\/cshperspect.a003962","article-title":"The role of transient receptor potential cation channels in Ca2+ signaling","volume":"2","author":"Gees","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41419-024-06809-0","article-title":"Trpv6 channel targeting using monoclonal antibody induces prostate cancer cell apoptosis and tumor regression","volume":"15","author":"Haustrate","year":"2024","journal-title":"Cell Death Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/emboj\/cdg080","article-title":"Homo- and heterotetrameric architecture of the epithelial Ca2+ channels TRPV5 and TRPV6","volume":"22","author":"Hoenderop","year":"2003","journal-title":"EMBO J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1016\/j.bmc.2013.03.037","article-title":"Design, synthesis and pharmacological characterization of analogs of 2-aminoethyl diphenylborinate (2-APB), a known store-operated calcium channel blocker, for inhibition of TRPV6-mediated calcium transport","volume":"21","author":"Hofer","year":"2013","journal-title":"Bioorgan Med. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1038\/s41467-018-06753-6","article-title":"Structural insights on TRPV5 gating by endogenous modulators","volume":"9","author":"Hughes","year":"2018","journal-title":"Nat. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e48476","DOI":"10.1371\/journal.pone.0048476","article-title":"Inside the mind of a medicinal chemist: the role of human bias in compound prioritization during drug discovery","volume":"7","author":"Kutchukian","year":"2012","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"7380","DOI":"10.1038\/sj.onc.1210545","article-title":"TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)\/NFAT-dependent pathways","volume":"26","author":"Lehen\u2019kyi","year":"2007","journal-title":"Oncogene"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1113\/jphysiol.2011.225862","article-title":"The role of TRPV6 channel in cancer","volume":"590","author":"Lehen\u2019Kyi","year":"2012","journal-title":"J Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"116379","DOI":"10.1016\/j.ejmech.2024.116379","article-title":"Advances in TRPV6 inhibitors for tumors by targeted therapies: macromolecular proteins, synthetic small molecule compounds, and natural compounds","volume":"270","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1126\/science.1116269","article-title":"Crystal structure of a mammalian voltage-dependent shaker family K+ channel","volume":"309","author":"Long","year":"2005","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4630","DOI":"10.1038\/s41467-023-40362-2","article-title":"Molecular pathway and structural mechanism of human oncochannel TRPV6 inhibition by the phytocannabinoid tetrahydrocannabivarin","volume":"14","author":"Neuberger","year":"2023","journal-title":"Nat. Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.str.2024.10.018","article-title":"Structure-function analyses of human TRPV6 ancestral and derived haplotypes","volume":"33","author":"Neuberger","year":"","journal-title":"Structure"},{"key":"B24","doi-asserted-by":"publisher","first-page":"9826","DOI":"10.1038\/s41467-025-65919-1","article-title":"The locking mechanism of human TRPV6 inhibition by intracellular magnesium","volume":"16","author":"Neuberger","year":"","journal-title":"Nat. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00424-003-1038-7","article-title":"(Patho)physiological implications of the novel epithelial Ca2+ channels TRPV5 and TRPV6","volume":"446","author":"Nijenhuis","year":"","journal-title":"Pflugers Arch."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1097\/01.asn.0000094081.78893.e8","article-title":"Localization and regulation of the epithelial Ca2+ channel TRPV6 in the kidney","volume":"14","author":"Nijenhuis","year":"","journal-title":"J. Am. Soc. Nephrol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1152\/physrev.00021.2006","article-title":"Transient receptor potential cation channels in disease","volume":"87","author":"Nilius","year":"2007","journal-title":"Physiol. Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1021\/ci500672v","article-title":"A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA","volume":"55","author":"Perryman","year":"2015","journal-title":"J. Chem. Inf. Model"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1158\/1535-7163.Mct-11-0965","article-title":"Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor\u2013negative breast cancer","volume":"11","author":"Peters","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.bbadis.2007.05.006","article-title":"TRP channels in cancer","volume":"1772","author":"Prevarskaya","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"B31","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/978-94-007-0265-3_49","article-title":"TRPV channels in tumor growth and progression","volume":"704","author":"Santoni","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature17975","article-title":"Crystal structure of the epithelial calcium channel TRPV6","volume":"534","author":"Saotome","year":"2016","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"14748","DOI":"10.1002\/anie.201507320","article-title":"Optimization of TRPV6 calcium channel inhibitors using a 3D ligand-based virtual screening method","volume":"54","author":"Simonin","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1038\/s41467-018-04828-y","article-title":"Structural bases of TRP channel TRPV6 allosteric modulation by 2-APB","volume":"9","author":"Singh","year":"2018","journal-title":"Nat. Commun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.12688\/f1000research.9664.2","article-title":"Kv4.2 knockout mice display learning and memory deficits in the lashley maze","volume":"5","author":"Smith","year":"2016","journal-title":"F1000Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3892\/or.2018.6216","article-title":"Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer corrigendum in\/10.3892\/or.2022.8395","volume":"39","author":"Song","year":"2018","journal-title":"Oncol. Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.7150\/jca.31640","article-title":"TRPV6 as A target for cancer therapy","volume":"11","author":"Stewart","year":"2020","journal-title":"J. Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"45489","DOI":"10.1038\/srep45489","article-title":"A gate Hinge controls the epithelial calcium channel TRPV5","volume":"7","author":"van der Wijst","year":"2017","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1074\/jbc.275.6.3963","article-title":"Permeation and gating properties of the novel epithelial Ca(2+) channel","volume":"275","author":"Vennekens","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.bbrc.2004.08.042","article-title":"TRPV6 and prostate cancer: cancer growth beyond the prostate correlates with increased TRPV6 Ca2+ channel expression","volume":"322","author":"Wissenbach","year":"2004","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"29304","DOI":"10.1038\/srep29304","article-title":"2-Aminoethoxydiphenyl borate potentiates CRAC current by directly dilating the pore of open Orai1","volume":"6","author":"Xu","year":"2016","journal-title":"Sci. Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.7150\/jca.20639","article-title":"Inhibition of transient receptor potential vanilloid 6 channel, elevated in human ovarian cancers, reduces tumour growth in a xenograft model","volume":"9","author":"Xue","year":"2018","journal-title":"J. Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small molecules in targeted cancer therapy: advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1097\/01.lab.0000043910.41414.e7","article-title":"Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies","volume":"82","author":"Zhuang","year":"2002","journal-title":"Lab. Invest"}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2026.1876502\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:35:15Z","timestamp":1785216915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2026.1876502\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":44,"alternative-id":["10.3389\/fchem.2026.1876502"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2026.1876502","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"1876502"}}